The Sydney Blood Bank Cohort: Implications for viral fitness as a cause of elite control

Current Opinion in HIV and AIDS

Volumn 6, Issue 3, 2011, Pages 151-156

  Zaunders, John ^a   Dyer, Wayne B ^b,c   Churchill, Melissa ^d,e  

^a ST VINCENT S HOSPITAL   (Australia)

^b AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d BURNET INSTITUTE   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

elite controllers; long term nonprogressors; nef deletion

Indexed keywords

ANTIRETROVIRUS AGENT; CD135 ANTIGEN; HLA DR ANTIGEN; NEF PROTEIN; NEUTRALIZING ANTIBODY;

AGE DISTRIBUTION; ALLELE; ARTICLE; BLOOD BANK; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE COURSE; GENE DELETION; GENE FUNCTION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRAL GENETICS; VIREMIA; VIRUS CELL INTERACTION; VIRUS REPLICATION;

AUSTRALIA; BLOOD BANKS; COHORT STUDIES; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRULENCE; VIRUS REPLICATION;

EID: 79955426303     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3283454d5b     Document Type: Article

References (43)

1. Learmont J, Tindall B, Evans L, et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992; 340:863-867.
2. Deacon NJ, Tsykin A, Solomon A, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995; 270:988-991.
3. Kestler HW, Ringler DJ, Mori K, et al. Importance of the nef gene for maintenance of high virus loads and for the development of AIDS. Cell 1991; 65:651-652.
4. Learmont JC, Gezcy AF, Mills J, et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. N Engl J Med 1999; 340:1715-1722. (Pubitemid 29252599)
5. Gorry PR, McPhee DA, Verity E, et al. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology 2007; 4:66.
6. Dyer WB, Zaunders JJ, Yuan FF, et al. Mechanisms of HIV nonprogression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after longterm transfusion-acquired HIV-1 infection. Retrovirology 2008; 5:112.
7. Gorry PR, Churchill M, Learmont J, et al. Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo. J Acquir Immune Defic Syndr 2007; 46:390-394. (Pubitemid 350098688)
8. Lodi S, Phillips A, Touloumi G, et al. CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era. AIDS 2010; 24:2697-2704.
9. Churchill M, Sterjovski J, Gray L, et al. Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia. J Infect Dis 2004; 190:2181-2186. (Pubitemid 39636367)
10. Churchill MJ, Rhodes DI, Learmont JC, et al. Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source. J Virol 2006; 80:1047-1052. (Pubitemid 43062917)
11. Zaunders JJ, Geczy AF, Dyer WB, et al. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes. AIDS Res Hum Retroviruses 1999; 15:1519-1527.
12. Giorgi JV, Liu Z, Hultin LE, et al. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1993; 6:904-912. (Pubitemid 23207458)
13. Verity EE, Zotos D, Wilson K, et al. Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions. J Virol 2007; 81:9268-9278. (Pubitemid 47311469)
14. Geczy AF, Kuipers H, Coolen M, et al. HLA and other host factors in transfusion-acquired HIV-1 infection. Hum Immunol 2000; 61:172-176. (Pubitemid 30075240)
15. Pushker R, Jacque JM, Shields DC. Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression. J Virol 2010; 84:3644-3653.
16. Navis M, Schellens IM, van Swieten P, et al. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef. J Infect Dis 2008; 197:871-879. (Pubitemid 351417011)
17. Bailey JR, Brennan TP, O'Connell KA, et al. Evidence of CD8+ T-cellmediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors. J Virol 2009; 83:88-97.
18. Ioannidis JP, Rosenberg PS, Goedert JJ, et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med 2001; 135:782-795. (Pubitemid 33051262)
19. Dyer WB, Geczy AF, Kent SJ, et al. Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection. AIDS 1997; 11:1565-1574. (Pubitemid 27460245)
20. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997; 278:1447-1450. (Pubitemid 27509814)
21. Wang B, Dyer WB, Zaunders JJ, et al. Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection. Virology 2002; 304:246-264. (Pubitemid 36069167)
22. Boaz MJ, Waters A, Murad S, et al. CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects. Clin Exp Immunol 2003; 134:454-463. (Pubitemid 37542086)
23. Malhotra U, Holte S, Dutta S, et al. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J Clin Invest 2001; 107:505-517. (Pubitemid 32167997)
24. Munier CM, Zaunders JJ, Ip S, et al. A culture amplified multiparametric intracellular cytokine assay (CAMP-ICC) for enhanced detection of antigen specific T-cell responses. J Immunol Methods 2009; 345:1-16.
25. Migueles SA, Laborico AC, Shupert WL, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3:1061-1068. (Pubitemid 35363659)
26. Dyer WB,Ogg GS, DemoitieMA, et al. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J Virol 1999; 73:436-443. (Pubitemid 28565388)
27. Pereyra F, Addo MM, Kaufmann DE, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 2008; 197:563-571. (Pubitemid 351321534)
28. Emu B, Sinclair E, Hatano H, et al. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol 2008; 82:5398-5407. (Pubitemid 351705247)
29. Braibant M, Xie J, Samri A, et al. Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain. Virology 2010; 405:81-92. Describes lack of protection from superinfection in an LTNP infected with nefdeleted HIV.
30. Wang B, Mikhail M, Dyer WB, et al. First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection. Virology 2003; 312:135-150. (Pubitemid 36918466)
31. Zaunders JJ, Dyer WB, Wang B, et al. Identification of circulating antigenspecific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood 2004; 103:2238-2247. (Pubitemid 38326243)
32. Norris PJ, Moffett HF, Yang OO, et al. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4+ T cells. J Virol 2004; 78:8844-8851. (Pubitemid 39025149)
33. Probasco JC, Deeks SG, Lee E, et al. Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation. AIDS 2010; 24:1001-1005.
34. Foster JL, Garcia JV. HIV-1 Nef: at the crossroads. Retrovirology 2008; 5:84.
35. Huang Y, Zhang L, Ho DD. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1995; 69:93-100. (Pubitemid 24378782)
36. Rhodes DI, Ashton L, Solomon A, et al. Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group. J Virol 2000; 74:10581-10588.
37. Xu W, Santini PA, Sullivan JS, et al. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat Immunol 2009; 10:1008-1017.
38. Moir S, Fauci AS. Nef, macrophages and B cells: a highway for evasion. Immunol Cell Biol 2010; 88:1-2.
39. Van Damme N, Goff D, Katsura C, et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008; 3:245-252. (Pubitemid 351494713)
40. Jia B, Serra-Moreno R, Neidermyer W, et al. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog 2009; 5:e1000429.
41. Zhang F, Wilson SJ, Landford WC, et al. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 2009; 6:54-67.
42. Sauter D, Schindler M, Specht A, et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 2009; 6:409-421.
43. Lim ES, Malik HS, Emerman M. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J Virol 2010; 84:7124-7134.